Changes in Work Environment Can Cut Cardiometabolic Risk
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 15, 2023 -- Increasing workplace flexibility is associated with a lower risk for cardiovascular disease, according to a study published online Nov. 8 in the American Journal of Public Health.
Lisa F. Berkman, Ph.D., from the Harvard Center for Population and Development Studies in Cambridge, Massachusetts, and colleagues examined whether workplace interventions to increase workplace flexibility and supervisor support and decrease work–family conflict can reduce cardiometabolic risk. The analysis included employees from information technology (555 employees) and long-term care (973 employees) industries in the United States who were randomly assigned to the Work, Family, and Health Network intervention or usual practice (2009 to 2013).
The researchers observed no significant main effect on the cardiometabolic risk score (CRS) associated with the intervention in either industry. However, among participants in both industries with a higher baseline risk score, the intervention had significant improvements in cardiometabolic risk at the 12-month follow-up. Intervention effects were moderated by age, with older employees having significantly larger reductions in CRS at 12 months than younger employees.
"The intervention benefited employee health by reducing CRS equivalent to five to 10 years of age-related changes for those with a higher baseline CRS and for older employees," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-16 02:21
Read more
- Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease
- Smoking Tied to Increased Opioid Use
- FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease
- Florida Fails to Pass Amendment Legalizing Recreational Weed
- Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain Syndrome
- ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions